SCHEMBL1713148

SCHEMBL1713148

Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CCNC(=O)C(C)(O)C(F)(F)F)c(F)c2)no1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3029787 0.81 BDKRB1 (0.61) BDKRB1
SCHEMBL3111713 0.80 BDKRB1 (1.00) BDKRB1
SCHEMBL1713005 0.80 BDKRB1 (1.00) BDKRB1
SCHEMBL3025187 0.80 BDKRB1 (0.81) BDKRB1
SCHEMBL2948330 0.79 BDKRB1 (0.56) BDKRB1
SCHEMBL2948332 0.79 BDKRB1 (0.56) BDKRB1
SCHEMBL13213870 0.79 BDKRB1 (0.70) BDKRB1
SCHEMBL2944102 0.79 BDKRB1 (0.63) BDKRB1
SCHEMBL12476169 0.78 BDKRB1 (0.57) BDKRB1
SCHEMBL12477168 0.77 BDKRB1 (0.67) BDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344176-A1 USE OF BRADYKININ B1 RECEPTOR ANTAGONISTS IN INTESTINAL FIBROSIS TREATMENT Jerini AG (DE) 2011-07-20 EP claimed
WO-2010031577-A1 USE OF BRADYKININ B1 RECEPTOR ANTAGONISTS IN INTESTINAL FIBROSIS TREATMENT JERINI AG (DE) 2010-03-25 WO claimed